1819. Characterizing Treatment Duration of Viridans Group Streptococci Bacteremia in Neutropenic Cancer Patients: Is 14 Days Necessary?

BACKGROUND: Neutropenic oncology patients often have mucosal barrier injury as a consequence of chemotherapy and are at risk of Viridans Group Streptococci (VGS) bacteremia. VGS is a commonly identified pathogen among oncology patients with neutropenic fever, however, limited data exists as to appro...

Descripción completa

Detalles Bibliográficos
Autores principales: Vu, Yaling, Wong, Jenny, Liu, Catherine, Tverdek, Frank P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752644/
http://dx.doi.org/10.1093/ofid/ofac492.1449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752644/
http://dx.doi.org/10.1093/ofid/ofac492.1449

Ejemplares similares